ACROCYTE
"ACROCYTE" is a word mark owned by Acrocyte Therapeutics Inc., filed at the USPTO on April 14, 2025. It is registered and covers classes 9, 42 and 44.
- Status
- Registered
- Since June 23, 2026
- Filed
- April 14, 2025
- Registered
- June 23, 2026
- Expires
- Not recorded
- Application no.
- 99135007
- Registration no.
- 8318727
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 3 classes
Who owns ACROCYTE
The owner and representative on file with the office.
Owner
Acrocyte Therapeutics Inc.
New Taipei City, Taiwan
Representative
Joseph Bruce
Bruce Stone LLP
What the mark covers
The products and services ACROCYTE is filed for, grouped by Nice class.
Cell culture apparatus for laboratory use, namely, cell culture dishes; Cell culture apparatus for laboratory use, namely, tissue culture flasks; Petri dishes used in laboratory research; Petri dish racks for laboratory use; Petri dishes; Lockable petri dishes used in laboratory research; Laboratory equipment, namely, microarrays; Plates, glass slides or chips having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use; Bioreactors for laboratory use; DNA chips; Bio-chips for research or scientific purposes; Bioreactors for cell culturing for scientific research; Bioreactor for cell culturing; Laboratory equipment and supplies, namely, incubators; Constant temperature incubators for laboratory use
Bacteriological research and testing; Executing of chemical analyses; Medical research; Medical and scientific research in the field of cancer treatment and diagnosis; Compiling data for research purposes in the field of medical science and medical consultancy; Bacteriological research; Biological research; Design, engineering, research, development and testing services in the field of polymeric materials, polymer synthesis, and materials customization for medical, scientific, and technological applications; Medical research laboratory services; Providing medical and scientific research information in the field of clinical trials; Biomedical research services; Genetic testing for scientific research purposes; Biotechnology research; Consulting services in the field of genetic science; Scientific research for medical purposes in the field of cancerous diseases
Providing medical information, consultancy and advisory services; Gene bank services; Providing information in the field of cancer prevention, screening, diagnosis and treatment; Medical screening; Clinical medical practice consultation services; Providing health information; Medical counseling; Medical analysis services for the diagnosis of cancer; Medical assistance; Medical treatment using cultured cells; Cultured cell bank services for medical transplantation; Medical examination; Drug screening for medical diagnosis and treatment; Medical testing services relating to the diagnosis and treatment of disease
What has happened so far
Steps recorded by the USPTO, newest first.
- Notice of registration confirmation emailed
- Registered-principal register
- Notice of acceptance of statement of use e-mailed
- Allowed principal register - sou accepted
- Statement of use processing complete
- Use amendment filed
- Teas statement of use received
- Noa e-mailed - sou required from applicant
- Official gazette publication confirmation e-mailed
- Published for opposition
6 earlier steps on the official record.
About ACROCYTE
Who owns the trademark "ACROCYTE"?
The USPTO trademark "ACROCYTE" (application 99135007) is owned by Acrocyte Therapeutics Inc.
What is the status of "ACROCYTE"?
Its status at the USPTO is: registered.
When was "ACROCYTE" registered?
It was registered on June 23, 2026.
Get this data via the API
Everything on this page comes from the Signa API. Pull ACROCYTE and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2aac-3d50-746e-83b5-7385b23fa0d0
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2aac-3d50-746e-83b5-7385b23fa0d0",
"object": "trademark",
"mark_text": "ACROCYTE",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "US",
"application_number": "99135007",
"filing_date": "2025-04-14",
"nice_classes": [
9,
42,
44
],
"owners": [
{
"name": "Acrocyte Therapeutics Inc.",
"entity_id": null
}
]
}